Scientists & Research
  Overview  
dashed line
Investigators
dashed line
  JFRC Scientists  
dashed line
  Early Career Scientists  
dashed line
  HHMI-GBMF Investigators  
dashed line
  International Early Career Scientists  
dashed line
  TB/HIV  
dashed line
  International Scholars  
dashed line
  Nobel Laureates  
dashed line
Scientific Competitions
dashed line
  FindSci  

Janelia Farm Research Campus
Learn about the new HHMI research campus located in Virginia. Moresmall arrow

Molecular Mechanisms of Gene Regulation and Ubiquitin Signaling


Summary: Cynthia Wolberger studies the molecular mechanisms underlying transcription regulation and ubiquitin signaling.

Protein function is dynamically regulated in the cell by the attachment and subsequent removal of covalent posttranslational modifications. The modifications can be small, as in the case of acetylation, or quite large, as in the case of a polyubiquitin chain. Acetylation and ubiquitination both occur in chromatin, the nucleoprotein complex into which eukaryotic DNA is packaged. Acetylation of the histone proteins in chromatin is associated with activation of transcription, whereas ubiquitination can be either an activating or a repressive mark, depending on which histone protein is modified. Ubiquitination of chromatin also plays a role in the response to DNA double-strand breaks, helping to recruit proteins that are required for DNA repair. We are interested in the molecular basis for these events, which ensure the integrity and expression of the genome. We use x-ray crystallography, enzymology, and a variety of biophysical tools to gain insights into the mechanisms underlying these essential cellular processes.

Ubiquitin Signaling
Ubiquitin is a small protein that regulates a wide array of cellular processes through its covalent conjugation to cellular proteins. In addition to its well-characterized role in targeting proteins for proteasomal degradation, there are now numerous examples of nondegradative roles for ubiquitin modification. Ubiquitin is attached to substrate lysines through a cascade of enzymatic reactions catalyzed by the E1, E2, and E3 enzymes. Downstream factors recognize the ubiquitin modification, which can consist of a single ubiquitin or a polyubiquitin chain composed of ubiquitin monomers joined by covalent bonds between the C terminus of one ubiquitin and one of the seven lysine side chains in the next ubiquitin. Polyubiquitin chains with different types of lysine linkages play distinct biological roles, as does monoubiquitin.

HHMI Media
media image

Sir2 enzyme...

media image

Model for Lys63-linked polyubiquitin assembly...

media image

O-alkylamidate intermediate (yellow) bound in the active site of the sirtuin, Sir2Tm.

media image

Polyubiquitin chains. Surface depictions of K63-linked tetraubiquitin and K48-linked tetraubiquitin.

media image

SAGA deubiquitinating module bound to ubiquitin.

Polyubiquitin Chain Assembly and Recognition
Lys63-linked polyubiquitin chains are nondegradative signals that play a role in DNA damage tolerance and the inflammatory response. We study the molecular basis for Lys63-linked polyubiquitin chain assembly and how these chains are attached to substrates. Lys63-linked chains are assembled by a specialized heterodimer that helps to catalyze formation of a covalent bond between Lys63 of one ubiquitin and the C terminus of the next. We determined the structure of the yeast enzyme Mms2/Ubc13 as well as that of the reaction intermediate in which the C terminus of ubiquitin is covalently joined to the active-site residue of Ubc13. In the structure, the unexpected binding of a donor ubiquitin of one Ub~Ubc13/Mms2 complex to the acceptor-binding site of Mms2/Ubc13 in an adjacent complex allowed us to visualize the molecular determinants of acceptor-ubiquitin binding and explain how Mms2 helps to orient ubiquitin to give rise to a Lys63-linked polyubiquitin chain. Our ongoing studies are focused on how Mms2/Ubc13 cooperates with the ubiquitin ligase Rad5 to attach Lys63-linked polyubiquitin chains to PCNA (proliferating cell nuclear antigen), which is a required step in the switch to error-free DNA repair in yeast. We are also studying the human homologues of these enzymes and how they are regulated in response to DNA damage.

Since linkage type determines the functional consequence of modification with polyubiquitin, there must be structural differences between different chain types that can be distinguished by the cell. We have determined structures of Lys48-linked tetraubiquitin and Lys63-linked tetraubiquitin and have used small-angle x-ray scattering to explore the conformation of these chains in solution. These two chains adopt distinct conformations that could be distinguished by ubiquitin-binding proteins that are sensitive to linkage type. Our ongoing studies are aimed at determining structures of proteins that bind preferentially to one or the other type of polyubiquitin chain, including deubiquitinating enzymes that cleave only one type of polyubiquitin linkage.

Monoubiquitination and the Regulation of Transcription
Eukaryotic genes are activated by macromolecular complexes that catalyze the addition and removal of posttranslational histone modifications, facilitating transcription through chromatin. The yeast SAGA complex has been a paradigm for understanding the connection between histone modifications and gene activation as well as the cross-talk between different types of modifications. SAGA functions in a cascade of posttranslational modifications that begins with monoubiquitination of histone H2B-Lys123 by the E2/E3 enzyme pair Rad6/Bre1. This triggers recruitment of a methyltransferase that methylates histone H3 at Lys4, which in turn triggers recruitment of the SAGA complex. SAGA removes monoubiquitin from histone H2B and acetylates histone H3. The transient ubiquitination of H2B is thought to be important for evicting nucleosomes from the transcribed region during transcription initiation and elongation. SAGA consists of 21 proteins that are widely conserved from yeast to humans and are organized into submodules with distinct functions.

We have been studying the SAGA deubiquitinating module (DUBm), a subcomplex of four proteins: the Ubp8 ubiquitin hydrolase and Sus1, Sgf11, and Sgf73, all of which are required for deubiquitination activity. We determined the structure of the DUB module with and without ubiquitin aldehyde, which revealed an unexpected intertwined arrangement of proteins. Three of the four proteins are nonglobular, adopting conformations that are dictated by their interactions with other DUBm subunits. The structure suggests how specific interactions with both Sgf11 and Sgf73 may position the Ubp8 active-site residues and ubiquitin-binding pocket, thus making Ubp8 active. We are testing these hypotheses with further structural and biophysical studies. We are also studying how the SAGA DUBm is targeted to monoubiquitinated histone H2B.

The Sir2 Family of NAD+-dependent Deacetylases
The Sir2 enzyme, which was first identified for its role in transcriptional silencing in yeast, is the founding member of an unusual class of enzymes that deacetylate lysine side chains in an unusual reaction that requires NAD+. Enzymes similar to Sir2 are found in virtually all organisms, where they are involved in a variety of critical biological processes, including transcriptional silencing, DNA repair, chromosome stability, and enzyme regulation. Sir2 proteins play an intriguing role in regulating life span, with high levels of Sir2 activity extending life span and low levels of Sir2 activity leading to a shortened life span in yeast, worms, and flies. Members of the Sir2 enzyme family, also known as sirtuins, also regulate important pathways in humans that are involved in protecting neurons from degeneration, fat mobilization, and cell death. More recently, it has been discovered that some sirtuins can also remove other types of acyl modification from residues such as propionyl- and butyryl-lysine. Understanding the novel chemistry of these enzymes and how it is exploited to regulate sirtuin activity in the cell has been an ongoing focus of our research.

We have been investigating the chemical reactions catalyzed by sirtuins by determining structures of these enzymes bound to a variety of substrates and products as well as in complex with reaction intermediates. Each of these structures has provided a snapshot of the reaction, beginning with the binding of sirtuins to acetylated peptide and NAD+, through the release of the products nicotinamide, O-acetyl ADP-ribose, and the deacetylated peptide. We have also determined the structure of a trapped covalent reaction intermediate bound to a sirtuin, which we were able to do by using a thioacetylated peptide. The structure of this complex revealed how side chains within the active site promote the initial cleavage of NAD+ and rearrange to promote subsequent steps in the reaction. These structures have shed light on the unique mechanism by which Sir2 enzymes catalyze the cleavage of NAD+ and the transfer of an acetyl group from the peptide lysine to ADP-ribose as well as how these enzymes are regulated by the metabolite nicotinamide. Mechanistic studies have also shed light on a by-product of sirtuin chemistry: the transfer of the ADP-ribose portion of NAD+ to a protein substrate, a reaction that is known as ADP ribosylation. Using mass spectrometry and protein microarrays in addition to x-ray crystallography, we have pinpointed the determinants for ADP ribosylation and identified the modified side chains.

We have also been studying the specificity of sirtuins for their substrates. Structural and thermodynamic studies with a variety of peptide substrates have shown how interactions between the enzyme and the substrate residues flanking the acetyl-lysine influence the peptide substrate specificity of the enzyme, while the structure of a sirtuin bound to a propionylated peptide has revealed how a subset of these enzymes can accommodate bulkier acyl modifications.

Portions of this work have been supported by the National Science Foundation and the National Institutes of Health.

Last updated July 01, 2011

HHMI INVESTIGATOR

Cynthia Wolberger
Cynthia Wolberger
 

Related Links

AT HHMI

bullet icon

Giving Chemistry a Second Chance

ON THE WEB

external link icon

The Wolberger Lab
(jhmi.edu)

search icon Search PubMed
dashed line
 Back to Topto the top
© 2012 Howard Hughes Medical Institute. A philanthropy serving society through biomedical research and science education.
4000 Jones Bridge Road, Chevy Chase, MD 20815-6789 | (301) 215-8500 | email: webmaster@hhmi.org